The panel's decision still must go to the CDC's interim director, Jim O'Neill, for sign-off. A former investor, critic of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback